Suchergebnisse - "Shah, Akshay"

PubPharm (162)

1

A Robust and Efficient Method to Purify DNA-Scaffolded Nanostructures by Gravity-Driven Size Exclusion Chromatography

enthalten in: Langmuir : the ACS journal of surfaces and colloids | 2024

von Ebrahimimojarad, A. | Wang, Z. | Zhang, Q. | +3

2

Iron Deficiency in Anemic Children Surviving Critical Illness : Post Hoc Analysis of a Single-Center Prospective Cohort in Canada, 2019-2022

enthalten in: Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies | 2024

von Du Pont-Thibodeau, G. | Li, S. | Ducharme-Crevier, L. | +10

3

Hypertonic Saline Versus Other Intracranial-Pressure-Lowering Agents for Patients with Acute Traumatic Brain Injury : A Systematic Review and Meta-analysis

enthalten in: Neurocritical care | 2024

von Bernhardt, K. | McClune, W. | Rowland, M. | +1

4

Fatigue after CriTical illness (FACT) : Co-production of a self-management intervention to support people with fatigue after critical illness

enthalten in: Intensive & critical care nursing | 2024

von Brown, S. | Shah, A. | Czuber-Dochan, W. | +2

5

CYCLOALKYL 3-OXOPIPERAZINE CARBOXAMIDES AND CYCLOHETEROALKYL 3-OXOPIPERAZINE CARBOXAMIDES AS NAV1.8 INHIBITORS

enthalten in: Europäisches Patentamt | 2024

von ARASAPPAN ASHOK | BELL IAN M | COX JASON M | +6

6

Response to "Letter to the Editor for 'Hypertonic Saline Versus Other Intracranial-Pressure-Lowering Agents for Patients with Acute Traumatic Brain Injury : A Systematic Review and Meta-analysis'"

enthalten in: Neurocritical care | 2024

von Bernhardt, K. | McClune, W. | Rowland, M. | +1

7

NAV1.8 억제제로서의 아릴 3-옥소피페라진 카르복스아미드 및 헤테로아릴 3-옥소피페라진 카르복스아미드

enthalten in: Europäisches Patentamt | 2024

von ARASAPPAN ASHOK | BELL IAN M | COX JASON M | +6

8

NAV1.8 억제제로서의 아릴 3-옥소피페라진 카르복스아미드 및 헤테로아릴 3-옥소피페라진 카르복스아미드

enthalten in: Europäisches Patentamt | 2024

von ARASAPPAN ASHOK | BELL IAN M | COX JASON M | +6

9

NAV1.8 억제제로서의 시클로알킬 3-옥소피페라진 카르복스아미드 및 시클로헤테로알킬 3-옥소피페라진 카르복스아미드

enthalten in: Europäisches Patentamt | 2024

von ARASAPPAN ASHOK | BELL IAN M | COX JASON M | +6

10

NAV1.8 억제제로서의 시클로알킬 3-옥소피페라진 카르복스아미드 및 시클로헤테로알킬 3-옥소피페라진 카르복스아미드

enthalten in: Europäisches Patentamt | 2024

von ARASAPPAN ASHOK | BELL IAN M | COX JASON M | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]